Johnson & Johnson Embarks on Supply Chain Restructuring

Key Regulatory Content

Johnson & Johnson has initiated a major supply chain restructuring project primarily focused on its innovative medicine segment. This strategic move aims to enhance operational efficiency and adapt to the rapidly evolving global pharmaceutical market.

Compliance Checklist

The restructuring involves the exit of certain facilities, incurring costs of up to 750 million dollars. The company must ensure strict adherence to regulatory requirements regarding asset disposal and facility closures during this transition period.

Risk Mitigation Measures

Given the significant financial investment, maintaining supply chain visibility and minimizing operational disruptions are critical. By optimizing its distribution network, J&J aims to achieve long-term cost savings and ensure a more resilient and reliable supply chain.

---

Original source: Supply Chain Dive